Company: PIII
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001140361-25-014596
Chunk: 49

Company: P3 Health Partners Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 49
---
ishing of any such report with the SEC when we granted stock options to Dr. Aric Coffman on May 9, 2024 in connection with Dr. Coffman’s appointment as our Chief Executive Officer effective on May 8, 2024. The following table provides the specific information concerning Dr. Coffman’s stock option award:

| Name         |     | Grant     
 Date(1)   |     | Number of  
 Securities 
 Underlying 
 the        
 Award      
 (#)        |            |    |     | Exercise     
 Price of the 
 Award        
 ($)          |      |    |     | Grant Date Fair 
 Value of the    
 Award(2)        |           |     | Percentage Change in the Closing Market Price   
 of the Securities Underlying the Award Between  
 the Trading Day Ending Immediately Prior to the 
 Disclosure of Material Nonpublic Information    
 and the Trading Day Beginning Immediately       
 Following the Disclosure of Material Nonpublic  
 Information(3)                                  |     |   |
|:-------------|:----|:----------|:----|:-----------|-----------:|---:|:----|:-------------|-----:|---:|:----|:----------------|----------:|:----|:------------------------------------------------|----:|:--|
| Aric Coffman |     | 5/09/2024 |     |            | 12,100,000 | -4 |     | $            | 0.73 | -4 |     | $               | 5,723,893 |     |                                                 | 2.5 | % |

| (1) | The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 and its Current Report on 
 Form 8-K announcing its financial results for the quarter ended March 31, 2024 were filed on May 8, 2024.  |

| (2) | Represents the grant date fair value of the award, computed in accordance with FASB ASC 718. |

| (3) | Based on closing prices of the Company’s common stock of $0.714 on May 7, 2024 and $0.732 on May 9, 2024. |

| (4) | These amounts do not reflect the Reverse Stock Split. |

32 DIRECTOR COMPENSATION We maintain a non-employee director compensation program (the “Director Compensation Program”). The Director Compensation Program provides for annual cash retainer fees and long-term equity awards for each of